Patents by Inventor Iris Pinheiro

Iris Pinheiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260224647
    Abstract: Described herein is a composition of two or more bacterial strains, wherein the composition comprises a bacterial strain of at least two of the following genera: Phascolarctobacterium, Veillonella, Eubacterium, Agathobacter, Lactiplantibacillus, and Anaerostipes. Aspects and embodiments described herein may be used in the treatment of joint inflammation, symptoms thereof, and underlying diseases and conditions.
    Type: Application
    Filed: January 29, 2024
    Publication date: August 6, 2026
    Applicants: Katholieke Universiteit Leuven, MRM Health N.V., Universiteit Gent, VIB vzw
    Inventors: Iris Pinheiro, Jolien Benedict Souffriau, Nicole Reichardt, Sam Possemiers, Selin Bolca, Suchita Panda, Anaïs Biclot, Dirk Elewaut, Emilie Dumas, Geert R.B. Huys, Jeroen Raes, Jorge Francisco VAZQUEZ CASTELLANOS, Lucas Ferreira Maciel
  • Publication number: 20250302894
    Abstract: Described herein is a composition comprising two or more bacterial strains belonging to at least two of the following genera: Faecalibacterium, Butyricicoccus, Roseburia, Akkermansia, Lactiplantibacillus or Anaerostipes. Aspects described herein may be used in the treatment of a disease or condition of the liver, a symptom thereof.
    Type: Application
    Filed: December 26, 2022
    Publication date: October 2, 2025
    Applicants: MRM Health N.V., Universiteit Gent
    Inventors: Tom Van de Wiele, Iris Pinheiro, Sam Possemiers, Selin Bolca, Joana Lopes, Suchita Panda
  • Patent number: 11324717
    Abstract: The present invention relates to the use of carotenoids, in particular a microbial carotenoid compound of formula I, such as methyl-glycosyl-apo-8?-lycopenoate or glycosyl-apo-8?-lycopene, for restoring and/or maintaining a health-beneficial gut microbial composition in a subject. The invention further provides the use of said compound in the treatment of disorders associated with a disturbed intestinal barrier integrity, such as for example irritable bowel syndrome. Further, a compound or composition comprising a microbial carotenoid compound is disclosed for use in the prevention and/or treatment of disorders associated with disturbed intestinal barrier integrity.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: May 10, 2022
    Assignee: Microbial Research Management Health NV
    Inventors: Sam Possemiers, Cindy Duysburgh, Iris Pinheiro, Selin Bolca, Pieter Van Den Abbeele, Massimo Marzorati
  • Publication number: 20190209516
    Abstract: The present invention relates to the use of carotenoids, in particular a microbial carotenoid compound of formula I, such as methyl-glycosyl-apo-8?-lycopenoate or glycosyl-apo-8?-lycopene, for restoring and/or maintaining a health-beneficial gut microbial composition in a subject. The invention further provides the use of said compound in the treatment of disorders associated with a disturbed intestinal barrier integrity, such as for example irritable bowel syndrome. Further, a compound or composition comprising a microbial carotenoid compound is disclosed for use in the prevention and/or treatment of disorders associated with disturbed intestinal barrier integrity.
    Type: Application
    Filed: June 22, 2017
    Publication date: July 11, 2019
    Applicant: ProDigest BVBA
    Inventors: Sam Possemiers, Cindy Duysburgh, Iris Pinheiro, Selin Bolca, Pieter Van Den Abbeele, Massimo Marzorati